May 22, 2017 10:00 PM ET


Company Overview of Syndax Pharmaceuticals, Inc.

Key Executives for Syndax Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Briggs W. Morrison M.D.16 RelationshipsChief Executive Officer and Director56
Michael A. Metzger M.B.A.8 RelationshipsPresident and Chief Operating Officer45
Michael Downes Ph.D.No RelationshipsCo-Founder--
Ronald M. Evans Ph.D.61 RelationshipsCo-Founder, Advisor and Chair of Scientific Advisory Board--
Richard A. Heyman Ph.D.43 RelationshipsCo-Founder59
View More Key Executives

Syndax Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis G. Podlesak MBA 31 RelationshipsDomain Associates, L.L.C.58
Briggs W. Morrison M.D. 16 RelationshipsSyndax Pharmaceuticals, Inc.56
Ronald M. Evans Ph.D. 61 RelationshipsSyndax Pharmaceuticals, Inc.--
Luke B. Evnin Ph.D. 98 RelationshipsBlade Therapeutics, Inc.53
Pierre Legault CA, MBA, CPA 54 RelationshipsPoxel SA55
View All Board Members

Syndax Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CA, MBA, CPAPierre Legault54 Relationships3 Executives
Compensation Committee Ph.D.Luke B. Evnin98 Relationships3 Executives
Nominating Committee MBADennis G. Podlesak31 Relationships3 Executives
Corporate Governance Committee MBADennis G. Podlesak31 Relationships3 Executives
Advisory Board Ph.D.Ronald M. Evans61 Relationships10 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$625.4K
Compensation as of Fiscal Year 2016
Syndax Pharmaceuticals, Inc. CEO Compensation
Industry Average


Osiris Therapeutics, Inc. Appoints Linda Chang as Chief Financial Officer, Effective from May 17, 2017
May 19, 2017 9:18 PM ET
Amgen Announces Board Changes
May 19, 2017 9:06 PM ET
Sirtex Medical Limited Announces the Cessation of Kevin Richardson as CEO of the Americas
May 18, 2017 3:42 AM ET
Sharklet Technologies, Inc. Announces Executive Changes
May 17, 2017 10:29 PM ET
Paion AG Announces Board Changes
May 17, 2017 2:07 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at